Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats

Abstract

BACKGROUND Erythropoietin (EPO) is widely used in diabetic patients receiving hemodialysis. The role of EPO in glucose homeostasis remains unclear. Therefore, we investigated the effect of EPO on hyperglycemia in rats with type 1-like diabetes. METHODS Rats with streptozotocin-induced type 1-like diabetes (STZ rats) were used to estimate the blood glucose… (More)
DOI: 10.2147/DDDT.S105867

Topics

6 Figures and Tables

Slides referencing similar topics